Key statistics
On Friday, LivaNova PLC (L2IV34:SAO) closed at 36.22, -4.28% below its 52-week high of 37.84, set on Dec 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 36.22 |
Low | 36.22 |
Bid | 30.93 |
Offer | 31.58 |
Previous close | 36.22 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jan 03 2025 19:54 GMT.
More ▼
Press releases
- CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
- LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
- LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
- LivaNova to Present at the Jefferies Global Healthcare Conference
- LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
- LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
More ▼